The Cinema Post Show Bigger Image of Facts
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) (Full FREE Analysis of BMRN And Be Sure To Notice The Intermediate Period) declared on Monday that the Ministry of Health, Labor and Welfare granted authorization of the registration of VIMIZIM (elosulfase alfa) for the treatment of patients with mucopolysaccharidosis type IVA (MPS IVA), as well …
Read More »BioMarin Pharmaceutical (NASDAQ:BMRN) on Active Notes with Walgreen (NYSE:WAG), TransCanada (NYSE:TRP), Vertex Pharmaceuticals (NASDAQ:VRTX)
